ARVN vs CLOV · rev $263.4M vs rev $1.37B
Arvinas Inc (ARVN) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Arvinas Inc (ARVN) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ARVN revenue for 2024-12-31 was $263.4M. Net income was -$198.9M. Revenue was up 235.5% from 2023-12-31 to 2024-12-31. ARVN currently screens at market cap $478.7M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ARVN currently screens at market cap $478.7M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ARVN and CLOV stock pages for the full models.
Not investment advice.